Niklas Engler
Global Head and Vice President, Technical Development Portfolio and Projects
F. Hoffmann-La Roche
Thomas Seewoester
Vice President, Site Operations
Amgen
James Warren
VP Pharmceutical Development
Ultragenyx
Tracy Ryan
Co-Founder & Chief Communications Officer
NKore BioTherapeutics
Fouad Atouf
Vice President, Science-Global Biologics
US Pharmacopeia
Kartik Subramanian, Ph.D.
Vice President, Biologics Product Development, Science and Technology
AbbVie
Colette Ranucci
Vice President, Global Large Molecules, Technical Operations
Merck
Nick Alden
Associate Director, Analytical Development Automation
Ultragenyx Pharmaceutical
Rosalind Ang
Associate Principal Scientist - Biologics & Analytical Research & Development
Merck (pending final confirmation)
Efecan Aral
Postdoctoral Associate, Cell Science and Technology
Sanofi
Andrei Arion
Associate Scientist, Cell Line and Upstream Process Development
Alexion, AstraZeneca Rare Disease
Regina Au
CEO, New Product Planning/Strategic Planning
BioMarketing Insight
Engin Ayturk
Senior Director, CMC BioConjugation, Process Development & Manufacturing
Exelixis
Jordan Ball
Sr. Manager, Technology Transfer
Regeneron
A Representative from Biophorum
-
BioPhorum
James Blackwell
President and Principal Consultant
The Windshire Group, LLC
Mark Blenner
Associate Professor
University of Delaware
Mr Rajeev Boregowda
Associate Director, Bioassay & Molecular Analytical Development, Genomic Medicine CMC
Mahesh Bule
Associate Director
Kite Pharma a Gilead Company
Daniel Burke
Senior Scientist
Michael Butler
Principal Investigator, Cell Technology
NIBRT
Ying Cai
MSAT Executive Director
Brenda Carillo-Conde
Group Leader
Pfizer
Wolfram Carius, PhD
Executive Vice President, Pharmaceuticals, Cell and Gene Therapy
Bayer Pharmaceuticals
Lina Chakrabarti
Associate Director, R & D
Astrazeneca
Callum Chapman
Senior Director, Product Quality
AstraZeneca
Thomas Chattaway
Senior Life Science Consultant
Independent
Jeron Chen
Head of Data Science and Payload Innovation
Voyager Therapeutics
Wei-Chiang Chen
Associate Director, BioProcess Analytics, Genomic Medicine Unit
Emma Cooper
Process Development Engineer
Kabir Dhingra
Yanhuai Ding
Sr . Director, CMC DS/DP
Evolve Immune Therapeutics
David Dobnik
Scientific Associate
National Institute of Biology
Mark Duerkop
Chief Executive Officer
Novasign, Austria
Mark Farmery
Chief Development Officer
Anocca AB
Aaron Fisher
Director, Life Sciences Investments
ARCHIMED
Daniel Friedman
Principal
BroadOak Capital
A Representative from Sanofi
,
Coral Fung Shek
Process Development Associate Scientist
Shireen Goh
Singapore University of Technology & Design (SUTD)
Jack Greene
Chief Technical and Manufacturing Officer
JucaBio
Jongyoon Han, Ph.D.
Professor, PI of the Micro-Nanofluidic BioMEMS group at RLE
Massachusetts Institute of Technology
Yuxin He
Sr Engineer II
Moderna
Chase Herman, Ph.D.
Investigator
GSK
Christoph Herwig
Senior Scientific Advisor
Körber Pharma Austria GmbH, Austria
Margit Holzer, Ph.D.
Scientific Director
Ulysse Consult S.a.r.L
Dr Wei Huang
President
Henlius Biopharmaceutical Ltd, China
David Humphreys, PhD
Executive Director and Head of Antibody and Novel Therapeutics
UCB Pharma
Christopher Hwang
Chief Technology Officer
Transcenta Holdings
Reagan Jarvis
Chief Executive Officer and Co-founder
Anocca
Hana Jug
Product Manager (Enveloped viruses, VLPs and EVs)
Sartorisu BIA Separations
Stephen Kennedy
Head of Technical Operations
CRISPR Therapeutics
Anis Khimani, PhD
Senior Strategy Leader
Revvity Inc
Erin Kimbrel
President & Head
Astellas Institute for Regenerative Medicine
Kat Kozyrytska
Managing Director
Kozyrytska Consulting
Elisabeth Krug
Executive Director, BRD Analytical Development
Eli Lilly & Company
Parag Kumthekar
Gene Therapy Downstream Process Development Lead
Kimberly Larson
Principal Scientist
Boehringer Ingelheim
Kelvin Lau
Principal Engineer
Abbvie
Kelvin Lee
Institute Director
NIIMBL
Jaeweon Lee, Ph.D
Student
University of Massachusetts Lowell
Marcus Lehmann
Associate Director, Drug Product Process Development
Satellite Bio
Abraham Lenhoff
Allan P. Colburn Professor
Seth Levy
Senior Director, Bioprocess Development
Modalis Therapeutics
Jun Li
Associate Director - Upstream Process Development: Gene Therapy
Weiyi Li
Senior Manager, LNP Formulation
Prime Medicine, Inc.
Yi Li
Process Development Scientist
Amgen, Inc.
Ana Di Lillo
Scientist
Yuxin Liu
Scientist, Cell Culture Platform
Yue Liu, PhD
CEO
Ab Studio Inc.
Jarrod Longcor
Chief Operating Officer
Cellectar Biosciences
Moira Lynch
Director, Innovation
Thermo Fisher Scientific
Junfen Ma
Head of Genomic Medicine Purification Process Development
Divyanshu Malhotra
Genmab
Victor Manuel Diaz Cortes
Research Director
OneChain Immunotherapeutics S.L.
Lynn Mao
Jeff Masten
Senior Vice President CMC
Secretome Therapeutics
Guy Matthews
Director - Market Development Single Use Technology
Fuji Film Irvine Scientific
Stefano Menegatti
North Carolina State University
Sara Miller
Director, Advanced Therapies Commercial Technical Lead
FUJIFILM Diosynth Biotechnologies
Bhanu Chandra Mulukutla
Shashi Murthy, PhD
CTO and Co-Founder
Nanite Inc.
Olga Paley, Ph.D.
Director, Head of mAb-Derived Biologics Process Development
Takeda
Prasad Pathange
Senior Manager
Bayer U.S.
Tracy Payne
SVP Business Development, Principal Consultant Business Strategy & Operations
Windshire Group, LLC. Labshire, LLC
Lorena Pena
Bristol-Myers Squibb
Lorraine Peters
Associate Scientist
Christine Pham
Principal Scientist, Purification Process Development
Gilead
Bryan Poltilove
Strategic Advisor and Independent Board Director
Shashi Prajapati
Director, Cell & Gene Therapies Analytical Development
Vertex Pharmaceuticals
Matthew Provencal
Executive Director Gene Therapy BDS Manufacturing
Sarepta
Monica Raimo
Director, Product and Process Development
Glycostem Therapeutics
Mr Phillip Ramsey
Senior Vice President, Technical Operations
Sangamo Therapeutics
Sidharth Razdan
Hunter Reese
Scientist II
Asklepios Biopharmaceutical
A Representative from Eli Lilly
Upstream Department
Eli Lilly
Keshab Rijal
Kate Rochlin
IN8bio
Ruth Salmon
VP, BMS Cell Therapy Research
Bristol Myers Squibb
Shruti Santhosh
Engineer II
Biogen
Nicole Santimauro
Senior Engineer, Manufacturing Science and Technology
Century Therapeutics, Inc.
Andreas Schaaf
CSO & Managing Director
Eleva GmbH
Dana Schreffler
Sr. Manager QC Viral Safety
Jacqualyn Schulman, Ph.D.
Scientist, Cell Line Development & ‘Omics Biologics Development
Susan Sharfstein, PhD
Professor of Nanobioscience, College of Nanoscale Science and Engineering
SUNY Polytechnic Institute
Amy Shaw
Head of Process and Product Development
Takeda, USA
Edwin Shen
Jindou Shi
PhD Student
GSK Center for Optical Molecular Imaging, UIUC
Wonjong Si
Associate Director, Cell Therapy Platform Process
Bayer
Yingnan (Michael) Si
Naveen Singh
Principal Scientist II, Process Development
Nripen Singh
Head of Process Development, TRD CGT
Novartis
Justin Skoble
Vice President of Technical Development
Caribou Biosciences, Inc.
Fernanda Sobreira
Associate Principal Scientist
Zhiwei Song
Senior Principal Scientist
A*STAR
Dr. Anand Srinivasan
Vice President of Technology and Innovations, and Head of the Center for Innovations and Biodesign
BioBridge Global
Arvind Srivastava, Ph.D.
Senior Vice President
ThirdArcBio
Xiaodong Sun
Shankar Swaminathan, PhD
Team Lead, Associate Director Drug Product Development
Ms Mariska ter Haak
Senior Director Analytical Development
Crystal Thomas
Process Engineer III
Sarah Thomas
Senior Vice President, Quality
REGENXBIO Inc.
Shawn (Xueyuan) Wang
Director, Process Development
Kite Pharma
Shu Wang
Principal Investigator
Incyte
Dhanuka Wasalathanthri, PhD
Mr William Whitford
Founder
Oamaru BioSystems
Kristy Wood, PhD
SVP, Technical Operations
Intellia Therapeutics
Jianlin (Jim) Xu
Global Head of Cell Culture Platform
Yifeng Xu
Dong Xu, Ph.D.
Associate Director, Cell Therapy Analytical Development
TScan Therapeutics
Ms Huize Yan
Spark Therapeutics
Lena Yang
Senior Scientist, Cell Therapy Analytical Development
Shu Yang
Linda Yi
Associate Director, Analytical Development
Gregory Zarbis-Papastoitsis, Ph.D
Chief Process and Manufacturing Officer
Ankyra
Hao Zhang
Sr. Principal Scientist
Zhengqi Zhang
Kate Zhao
Scientist I, Upstream Process Development
Yuxiang (Henry) Zhao
Yuechen Zhu
Staff Development Scientist